Literature DB >> 9142924

Sumatriptan, a selective 5-HT1 receptor agonist, induces a lag phase for gastric emptying of liquids in humans.

B Coulie1, J Tack, B Maes, B Geypens, M De Roo, J Janssens.   

Abstract

Sumatriptan, a 5-hydroxytryptamine1 (5-HT1) receptor agonist at enteric neuronal 5-HT receptors, causes a relaxation of the gastric fundus and inhibition of antral contractile activity. The present study examined the effect of sumatriptan on gastric emptying of solids and liquids in humans. In eight healthy subjects the gastric emptying rate for liquids and solids was measured using the carbon-labeled glycine and octanoic acid breath test after subcutaneous administration of placebo or sumatriptan. Sumatriptan increased the gastric half-emptying time of liquids (P < 0.0005) and induced a prolonged lag phase for liquids (P < 0.0005) in all subjects. Sumatriptan increased gastric half-emptying time (P < 0.005) and the lag phase of solids (P < 0.05) in all subjects. In two healthy subjects gastric emptying of liquids and solids after subcutaneous administration of sumatriptan was studied by radioscintigraphy. Radioscintigraphy confirmed the delayed emptying and the prolonged lag phases after sumatriptan. In conclusion, sumatriptan delays gastric emptying of solids and liquids in healthy subjects. Moreover, sumatriptan induces a lag phase for liquids. The mechanism by which sumatriptan alters gastric emptying remains to be studied.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9142924     DOI: 10.1152/ajpgi.1997.272.4.G902

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  21 in total

1.  Treatment functional GI disease: the complex pharmacology of serotonergic drugs.

Authors:  Fabrizio De Ponti; Francesca Crema
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

Review 2.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

3.  Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans.

Authors:  B Coulie; J Tack; T Peeters; J Janssens
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

4.  Effect of sumatriptan on gastric emptying: a crossover study using the BreathID system.

Authors:  Yasunari Sakamoto; Yusuke Sekino; Eiji Yamada; Takuma Higurashi; Hidenori Ohkubo; Eiji Sakai; Hiroki Endo; Hiroshi Iida; Takashi Nonaka; Koji Fujita; Masato Yoneda; Tomoko Koide; Hirokazu Takahashi; Ayumu Goto; Yasunobu Abe; Eiji Gotoh; Shin Maeda; Atsushi Nakajima; Masahiko Inamori
Journal:  World J Gastroenterol       Date:  2012-07-14       Impact factor: 5.742

Review 5.  New developments in the treatment of functional dyspepsia.

Authors:  Vincenzo Stanghellini; Fabrizio De Ponti; Roberto De Giorgio; Giovanni Barbara; Cesare Tosetti; Roberto Corinaldesi
Journal:  Drugs       Date:  2003       Impact factor: 9.546

6.  Alterations in expression of p11 and SERT in mucosal biopsy specimens of patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Christopher N Andrews; Adil E Bharucha; Paula J Carlson; Irene Ferber; Debra Stephens; Thomas C Smyrk; Raul Urrutia; Jeroen Aerssens; Leen Thielemans; Hinrich Göhlmann; Ilse van den Wyngaert; Bernard Coulie
Journal:  Gastroenterology       Date:  2006-11-17       Impact factor: 22.682

7.  Assessment of Gastric Accommodation by SPECT.

Authors:  Sung Pyo Hong
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

8.  Assessment of meal induced gastric accommodation by a satiety drinking test in health and in severe functional dyspepsia.

Authors:  J Tack; P Caenepeel; H Piessevaux; R Cuomo; J Janssens
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

9.  S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome.

Authors:  Akiko Shiotani; Hiroaki Kusunoki; Yoshiki Kimura; Mnabu Ishii; Hiroshi Imamura; Ken-ichi Tarumi; Noriaki Manabe; Tomoari Kamada; Jiro Hata; Ken Haruma
Journal:  Dig Dis Sci       Date:  2013-04-18       Impact factor: 3.199

10.  Adjustable totally implantable intragastric prosthesis (ATIIP)-Endogast for treatment of morbid obesity: one-year follow-up of a multicenter prospective clinical survey.

Authors:  Giorgio Gaggiotti; Jan Tack; Arthur B Garrido; Miquel Palau; Giovanni Cappelluti; Fabio Di Matteo
Journal:  Obes Surg       Date:  2007-07       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.